The process of diagnosing diabetes mellitus cannot be regarded as an exact science. It has evolved over many years and even now continues to change as our knowledge and perception of the condition alter. In the majority of cases the diagnosis is not difficult, but a dilemma does exist in the rather wide and hazy zone between normality and obvious diabetes. There are also certain situations, such as pregnancy, where special factors apply and which require separate consideration. Of course, diabetes mellitus is not a single entity. It comprises different types with different aetiologies, e.g. type I (insulindependent), type II (non-insulin-dependent), maturity onset diabetes of the young, etc., and these may present in different ways, be attended by different complications and require different methods of treatment. Nevertheless, they are all associated with greater or lesser degrees of carbohydrate intolerance and current methods of diagnosis usually depend on this without providing any differentiation by type.
REASONS FOR DIAGNOSING DIABETES MELLITUS
The prevalence of diabetes mellitus in the population of Great Britain has been estimated at between 1010 and 2010, with the Asian community returning slightly higher figures (approximately 2·2010). This means that a million people may be affected and the care of this number of patients with a life-long condition is a significant burden for the National Health Service. Furthermore, both false positive and false negative diagnoses can result in money being wasted, the former if the patient receives unnecessary medical attention and the latter if omission of treatment leads to complications, e.g. visual impairment, nephropathy and neuropathy, which require more attention from medical and social services. At a personal level, there is a lifelong stigma attached to a diagnosis of diabetes and it can have implications for employment, driving and insurance with financial, legal and psychological consequences.
In practical terms, therefore, it is necessary to identify those individuals who would be expected to benefit from monitoring and treatment to control their condition and to separate them both from those who are normal and from those who have a degree of carbohydrate intolerance that, in the light of current clinical experience, would not be severe enough to produce either short-or long-term problems. This means that it is not sufficient to base diagnostic criteria for diabetes simply on the 95th centile for glucose tolerance in the population, as is commonly employed for reference values in clinical biochemistry. A measure of clinical risk must be incorporated, otherwise the prevalence would be set statistically at 5010 for the population in which the criteria were established, independent of whether it had greater or lesser degrees of glucose intolerance than another population. It should be remembered that, although raised blood glucose is a sign of diabetes, the two are not necessarily synonomous and the severity of diabetic complications does not always correlate with the degree of glucose intolerance. Nevertheless, glucose tolerance is the parameter that has been and continues to be used for diagnostic purposes.
CLASSIFICAnON OF GLUCOSE INTOLERANCE
Over the years, many different protocols and criteria have been employed for the assessment of glucose intolerance resulting in widely differing estimates of diabetes prevalence. The age of the population also has an influence, as glucose tolerance decreases with increasing age, especially above 50 years.' In 1975, even clinical experts in diabetes were found to be using quite different diagnostic criteria, some of which would give very high prevalence figures.? Since then, there has Wiener been a gradual movement towards national and international standardization and a realization that diabetes was being over-diagnosed.
Impaired glucose tolerance
The above realization led to the official recognition in 1979 by the National Diabetes Data Group (NDDG) in the USA of the term impaired glucose tolerance (lGT) to classify the intermediate group of subjects whose glucose tolerance was neither normal nor definitely diabetic." This was subsequently endorsed by the World Health Organisation (WHO) in its second report on diabetes mellitus." Previously, these subjects would have been classified as diabetic or under such names as chemical diabetes, latent diabetes, pre-diabetes, etc., but this terminology is now considered obsolete.
Evidence in support of the IGT classification came from several long-term prospective studies that followed subjects for up to 10 or 12 years, observing changes in glucose tolerance over that period. It became apparent that mild degrees of glucose intolerance did not always progress to diabetic levels. In fact, the rate of progression varied from 10/0 to 5% per annum, i.e. between 10% and 50% of subjects in this intermediate category went on to become diabetic within 10 years, and the rate correlated with the initially observed plasma glucose level 2 h after a glucose load. [5] [6] [7] [8] [9] [10] [11] [12] [13] In the Birmingham Diabetes Survey over 10 years, 50% of borderline diabetic subjects remained in that category, 5% reverted to normal and 45% became diabetic, while in another group with a smaller degree of intolerance only 20% deteriorated, 50% remained in the same category and 2% reverted to norrnal.v" With few exceptions, other population studies have produced similar findings. 14-23 Moreover, IGT seems not to be associated with increased risk of retinopathy or nephropathy. [5] [6] [7] [8] 12 There may be increased susceptibility to atherosclerotic disease, but this is not firmly established as other factors such as hypertension, hyperlipidaemia, obesity, etc., are usually present. [24] [25] [26] [27] [28] [29] In view of the apparently low risk of diabetic complications in individuals with IGT, most informed opinion in recent years has been in favour of maintaining this category as a separate entity in its own right, but with subjects within it requiring periodic investigation to detect any change in status towards diabetes, for which treatment would be required. Re-testing at about 6 months after the diagnosis of IGT and an annual check of blood glucose thereafter may be all the monitoring that is needed, but this would depend on the degree of carbohydrate intolerance first observed. Dietary restriction is usually unnecessary.
The wisdom of putting patients into this category has been challenged by Jarrett" who, while accepting the existence of the phenomenon, regards it as an unstable state with the risk of progression to diabetes being influenced by the degree of glucose intolerance within the category. He also feels that it unnecessarily attracts the attention of insurance companies to people who are not diabetic.
In contrast to most findings, some populations show a relatively high rate of progression from IGT to diabetes. A study of Pima Indians, in whom there is a hereditary high prevalence of diabetes (approximately 25%), also showed a high rate of deterioration from IGT to diabetes of between 5% and 6% per year over 10 years. 31, 32 In populations with such a high prevalence of diabetes, the pattern of plasma glucose levels 2 h after a glucose load shows a bimodal distribution with normal and diabetic modes. In other communities with lower diabetic prevalence, the pattern is unimodal with some skewing to higher values. Stern et al. 33 suggested that the category of IGT contained a heterogeneous group of individuals that could be sub-divided into three:
(a) those in the upper tail of normal glucose tolerance (b) those in the lower tail of diabetic subjects (c) those with true IGT However, because the latter must be present only in small numbers for them to appear as a trough between the two modes, they regarded IGT as a transition stage towards diabetes. Yudkin et al. 34 applied this discussion more generally to other populations, suggesting that intra-individual variance in the glucose tolerance test (GTT) and inter-individual differences in the population may cause blurring of the classification. They concluded that criteria in addition to glucose measurements were needed to categorize people with IGT.
METHODS OF DIAGNOSIS
The oral glucose tolerance test (OGTI) Since its introduction in 1913, the GTT has been the definitive test for diabetes mellitus but it is often sufficient to measure fasting or random plasma glucose to establish a diagnosis if the patient has symptoms consistent with the condition, e.g. thirst, polydipsia and polyuria, usually with demonstrable glycosuria. In such cases a random venous plasma glucose in excess of II . 1 mmollL or a venous whole blood glucose greater than 10· 0 mmollL is usually considered to be diagnostic, as is a true fasting plasma glucose above 7· 8 mmollL or a true fasting venous glucose above 6' 7 mmollL. However, owing to the difficulty of ensuring adequate fasting, the WHO no longer recommends using fasting glucose concentrations as the sole criterion for diagnosis.P Those subjects who are less overtly diabetic require more critical investigation and the OGTT is still the test of choice, performed according to the WHO protocol," which is given in the Appendix at the end of this review.
Variability of response in the OGTT One of the major problems in the use of the OGTI is the variability of response that is shown by individuals from one occasion to another'. [36] [37] [38] [39] [40] [41] [42] [43] Coefficients of variation (CV) of between 20070 and 35070 have been reported for the 2-h glucose value independent of glucose tolerance class. However, Cummings and Fraser'? found a CV of abo~t 11070 in non-diabetic individuals each subjected to 10 OGTTs at intervals of 1 week. This biological variation is difficult to control but some variation in the performance of the test also occurs and this could be minimized by more careful attention to protocol. 45 Careful use of, and adherence to, internationally agreed procedure for the OGTT is especially important in epidemiological studies when comparison with other studies is required.
Factors that can affect the OGTT The results of the OGTT can be influenced by a number of factors during and before the performance of the test (Table 1) .
Preparation of the patient
It is important that the patient is properly prepared for the test. The OGTT should be performed in the morning after an overnight fast of between 10 and 16 h. A fast shorter than 10 h can result in a starting plasma glucose that is not truly baseline, whereas prolongation beyond 16 h can cause impairment of tolerance." A diurnal variation in OGTI has been reported with poorer tolerance in the afternoon compared with the morning. 47 -49 However, in some cases this may Carbohydrate intake of less than 150 g per day for several days before an OGTT can cause an abnormal result, as can a period of physical inactivity such as an illness, especially if associated with bed rest. 46 There is evidence that physical inactivity is accompanied by increased circulating insulin and decreased peripheral sensitivity to it, possibly as a result of decreased capillary bed surface area. The influence of muscular activity on glucose tolerance is partly the reason for the usual recommendation that the patient should remain sitting quietly during the OGTT.
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There appears to be no evidence that water intake during fasting has any effect on subsequent glucose tolerance, but some laboratories do restrict water intake along with food intake." This seems unnecessarily harsh and a reasonable volume of water is permissible; other beverages, however, should be prohibited. Caffeine has been shown to be capable of affecting plasma glucose. 51 -53 A rise in blood glucose has also been observed within 15 min of smoking a cigarette, with a gradual return to baseline after a further 30 min. 54 Smoking on the morning of the test should, therefore, be prohibited. It has been suggested that nicotine stimulates adrenaline release which has a glycogenolytic effect.
Various drugs can influence glucose tolerance ( Table 2 ) and details of a patient's current Agents reported to lower blood glucose concentration The 50 g load formerly used in Britain is considered by some to be an inadequate challenge, while the 100 g dose previously favoured in the USA is more likely to provoke nausea and vomiting owing to its greater osmotic effect in the gut. A compromise figure of 75 g was therefore settled upon, but some controversy still remains because no advice was given as to what form of glucose should be employed, i.e. anhydrous or monohydrate.t-v" In its first report in 1965, the WHO specified 50 g of the monohydrate. 56 Later reports simply refer to 'glucose'. This ambiguity has led to confusion and common use of both types of glucose for routine diagnostic purposes and for research and epidemiological studies, introducing a variation in load of 100/0. Suggestions that 75 g of the monohydrate may be the better choice have been challenged by representatives of the WHO, who now prefer to use 75 g of anhydrous glucose or 82· 5 g of the monohydrate. 57-6O It is likely that this question will be officially resolved by the WHO publishing advice in line with its current opinion in a future report, but despite this, many workers around the world will probably carryon oblivious of which form of glucose they are using.
Glucose powder is best dissolved in about 150 mL of hot water and then cooled by adding ice and cold water to dilute it to about 300 mL before asking the patient to drink it. Fruit flavourings have been used to make the solution more palatable and, as an alternative to glucose solution itself, there is increasing use of commercial polysaccharide solutions, e.g. Lucozade, Hycal (SmithKline Beecham, Brentford, UK) and Fortical (Cow and Gate, Trowbridge, UK). These preparations are considered to give valid results in the OGTT.4.61 As they are less sweet, they are more acceptable to the patient and decrease the incidence of vomiting, presumably partly because of their reduced osmotic effect. Lucozade formerly had the disadvantage of containing some caffeine, but no longer does, making it now more theoretically acceptable for this purpose. The manufacturers of such products can provide advice on their use for glucose tolerance testing. Seventy-five grams anhydrous glucose (82' 5 g glucose monohydrate) is equivalent to 388 mL Lucozade, 166 mL Hycal or 113 mL Fortical.
Whatever form of glucose is used, the usual recommendation is to administer it in approximately 300 mL of water to give an acceptable osmolality. However, the use of this concentration has been challenged by Schwartz 
Administration of the glucose load
Although glucose loads of 50 g and 100 g have been used for diagnostic purposes, the internationally recommended quantity is now 75 g.3.36 However, 100 g is still being used by some workers for diagnosis of gestational diabetes (see later). It has not been considered necessary to take into account body weight except for children, in whom a dose of 1'75 g per kg body weight is recommended by the WHO, up to a maximum of 75 g. 35 Plasma Whole blood points in the test are considered to be at the start, when fasting, and at 2 h after the glucose load, with most reliance being placed on the latter. However, in the author's experience, the fasting level in an individual does influence the 2 h figure and some of the intra-individual variation of 2 h values in repeated OOTTs probably stems from variation in the day-to-day fasting level. Hence, the 2 h glucose value cannot be regarded as an entirely independent parameter of glucose tolerance after a glucose load, even when fasting has been performed correctly. In other words, the finishing point is influenced by the starting point.
The intermediate glucose levels during the OOTT are considered to be of less importance and even high values at 30 min or I h tend to be disregarded if the 2 h value is within normal limits. Sometimes, a rapid rise in blood glucose occurs with a peak between 30 min and I h followed by a rapid fall to a normal level by 2 h. This is the so-called lagstorage curve, which often occurs in patients who have had gastric surgery, when it is caused by rapid transit through the gut. It may be accompanied by reactive hypoglycaemia at about 3 h (dumping syndrome). The lag storage curve may also be seen in hyperthyroidism and occasionally in liver disease. Some apparently normal subjects also show a similar response. It has been suggested that this may indicate susceptibility to later development of diabetes. The Birmingham Diabetes Survey Working Party estimated that about 9% of the normal population would exhibit this type of response." Fiveyear follow-up revealed that most of those Interpretation of the OGTT The general criteria for interpretation according to the WHO are shown in Table 3 . The important
Specimen collection and analysis
During the OOTT, venous or capillary blood samples may be collected and the analysis may be performed either on whole blood or separated plasma. Fasting capillary and venous blood samples have similar glucose concentrations, but post-prandial capillary levels are usually higher than venous ones. Furthermore, glucose concentrations measured in plasma are usually higher than those in whole blood by about 151170. Hence, in the OOTT, glucose results require interpretation against the appropriate criteria and the WHO has published four sets of these to cater for specimen differences (Table 3) . 35 It can be seen that the critical values differ significantly, by over 20% at the extremes, and application of the wrong criteria can lead to serious misdiagnosis.
of 300 mL, which they considered to be the standard test, caused delayed gastric emptying when compared with a modified load of 50 g in a volume of 450 mL, which they proposed as a better alternative. They found that, using the 100g load, much of the glucose had not entered the peripheral circulation by the end of the test. Despite some criticism of this studY,63 Schwartz et al. maintained'" that their modified procedure should lead to greater reproducibility of the OOTT with better differentiation of patient groups and easieridentification of lOT. Furthermore, they suggested that it might be possible to curtail sampling at 60 min rather than continue up to 2 h. Whilst these suggestions cannot be discounted out of hand, putting them into practice would cause a major upheaval in OTT protocol and interpretative criteria would have to be entirely reviewed, so it is unlikely that they will gain acceptance.
The rate of ingestion of the glucose load was investigated by Heine et al. 6 5 in non-diabetic subjects using 75 g of glucose in 300 mL. Two rates of ingestion were compared, over I min and over 10min. The faster intake produced an earlier rise in blood glucose, but a significantly lower value at 2 h (mean 4· 7 mmol/L compared with 5· 5 mmol/L after a 10 min intake). When Hycal was used, a similar difference at 2 h was observed. The authors, therefore, recommended the adoption of a standard time for ingestion of the glucose. In fact, ingestion over 5 min is usually suggested with timing of the test beginning at the start of ingestion.
initially showing this feature either continued to do so or had reverted to normal, but approximately 13010 had converted to a diabetic curve, which led them to conclude that lag storage could not be regarded as entirely innocent and that such individuals should be reviewed every 5 years. Nevertheless, the lag storage curve is nowadays usually regarded as a variant of a normal response. It is, however, likely to be accompanied by some glycosuria and indeed this may be reason for requesting the OGTT.
Flat glucose tolerance curves occur in some cases of endocrine deficiency such as hypopituitarism, hypoadrenalism or hypothyroidism and in malabsorptive conditions. Some otherwise normal individuals also exhibit this type of curve.
It should be noted that elderly subjects, as a group, tend to have diminished glucose tolerance compared with the younger population, but this should not lead to misdiagnosis of diabetes using the WHO 1985 criteria, as it did using some of the older systems.
The intravenous GTT
The intravenous GTT is rarely used nowadays. It involves the infusion of a glucose solution into a vein over a period of a few minutes. Loads of about 25 g (50 mL of a 50% w/v solution) have mostly been used. In theory, it has the advantage of bypassing the variability of the absorption stage, but it is an unphysiological way of presenting carbohydrate to the body and eliminates the effect on carbohydrate handling of gut hormones such as gastric inhibitory peptide (GIP), produced in response to carbohydrate in the gut. The intravenous GTT does, however, remove variation due to variable gastric emptying or malabsorption and has been used for research concerned with rates of glucose uptake by tissues.P Other tests for diabetes Attempts have been made to use more convenient tests than the OGTT for diagnosing diabetes, but none has proved to be a completely successful substitute. The presence of glycosuria after a meal has been employed in population surveys as a crude way of picking up cases for further investigation.f-? High false negative rates for the urine test were reported in these surveys in the 1960s, when diagnostic criteria for diabetes were a little different from present criteria, and a recent survey in general practices? did not confirm these findings. However, the patients in the latter study were aged 45 to 70 years and some older patients with raised renal thresholds would be excluded.
Other studies have used fasting or random plasma glucose levels. In 1980, the WHO recommended measuring a random or a fasting plasma glucose concentration as an initial screen for diabetes mellitus in symptomatic patients, with a diagnostic value for random venous plasma of 11 mmollL and for fasting venous plasma of 8 mmollL. 2 In its 1985 report, the fasting value was omitted owing to the difficulty of ensuring adequate fasting and the random venous plasma figure was changed to 11·1 mmollL. Using frequency plots for a large number of patients, Ito et al. 18 concluded that 8· 3 mmollL was the logical threshold value for diagnosis of diabetes when based solely on fasting plasma glucose concentration. However, while simple tests of this sort may be sufficient for diagnosis in the more severe cases, a glucose challenge is needed in the less obviously abnormal ones.
Haemoglobin Ale (HbA le) has been studied as a possible alternative to the OGTT, but Santiago et al. 68 found that only about half of the patients diagnosed as having mild diabetes had elevated HbA le and that plasma glucose 2 h after a 100 g carbohydrate meal needed to be greater than about 12'7 mmollL before HbA le was raised. Similarly, Dods and Bolneys? found that between 37% and 64% of individuals judged to be diabetic by OGTT, depending on criteria used, would be classified as non-diabetic on HbA I results. Lester et al. 70 found the latter to be slightly more sensitive for detecting borderline decreased glucose tolerance. However, even if the sensitivities of the glycated haemoglobin and fructosamine tests were~onsidered appropriate, their universal application for diagnostic purposes would present problems, because standardization of both tests is difficult and various analytical techniques are used for their measurement. Consequently, reference ranges differ from one laboratory to another and it would be impossible at present to issue universally applicable recommended criteria for diagnostic interpretation. Neither test therefore can be recommended for diagnostic purposes at the moment.
Of course, one of the problems associated with assessment of tests for diabetes is that the 'gold standard' for diagnosis is the OGTT, which is itself far from perfect. In fact, in 1975 Siperstein, in an extensive review, 75 criticized the OGTT as it was then being used in the USA, saying that it led to gross over-diagnosis of diabetes. He advocated that the diagnosis should only be made if true fasting plasma glucose was consistently above 7· 8 mmol/L on two, and preferably three, separate occasions. This criticism applies even more strongly to the old cortisone GTT that was introduced in 1954 as an even more sensitive indicator of glucose intolerance;"
In recent years, research on HLA histocompatibility testing has revealed the presence of particular HLA patterns in certain forms of diabetes. Although these seem to confer a susceptibility to diabetes, they are not invariably associated with its development in an individual and so cannot be used diagnostically. Another avenue that shows some promise is the finding of increased concentrations of intact and split proinsulin in some non-insulin-dependent diabetics and a possible association with increased cardiovascular risk. 77 -79 These insulin precursors are often measured by conventional insulin immunoassays and the use of more specific methods may be helpful in the future in categorizing some types of patient with glucose intolerance in the difficult area of IGT.
DIABETES MELLITUS IN PREGNANCY
Pregnancy and diabetes mellitus can be associated in two ways. A diabetic woman can become pregnant and a pregnant woman can become diabetic, the latter condition being referred to as gestational diabetes. This is an important distinction. In both cases the woman's diabetes may need to be carefully monitored and controlled throughout her pregnancy in order to minimize risks to the fetus, such as macrosomia, congenital malformations and increased perinatal morbidity and mortality. Indeed, work in rats has suggested that gestational hyperglycaemia can actually result in the production of diabetic offspring.s? However, the gestational diabetic should not be labelled 'diabetic' in perpetuity and should be reassessed when her pregnancy is over, 
Diagnosis of gestational diabetes
As implied above, gestational diabetes is defined as glucose intolerance first detected during pregnancy. Although this may seem a straightforward matter, it is actually an area of considerable controversy and there is no international consensus on the most suitable method and criteria for its diagnosis. The method still widely employed in the USA is based on the work of O'Sullivan and Mahan'" in the 1950s and '60s, in which a 100 g load of glucose was administered and measurements of blood glucose performed when fasting and at I h, 2 hand 3 h after the dose. An unselected group of 752 pregnant women was studied and the criteria for diagnosis were defined from this, statistically, as two or more blood glucose values during the test greater than two standard deviations above the mean ( Table 4 ). The validation of this approach resided in a second study of 1013 selected non-diabetic pregnant women on whom the same glucose tolerance test was performed during pregnancy and then annually for up to 8 years when not pregnant. Assessment of the non-pregnant OGTTs was made against the US Public Health Service criteria;" This again utilized blood glucose concentrations when fasting and I h, 2 h and 3 h after 100 g of glucose, but involved a points score based on which and how many of these concentrations were above specified threshold values. Using this approach, O'Sullivan and Mahan found that 29% of the women whose pregnancy OGTT results had been greater than the criteria previously set went on to become diabetic later when not pregnant, compared with 170/0 of those with glucose values below the criteria. The more abnormal the pregnancy OGTT, the greater the risk of later diabetes. When considering these figures, it should be noted that the cohort was selected so as to include a high proportion of subjects at risk for gestational diabetes by virtue of clinical factors such as obesity and family history of diabetes, etc.
Considerable criticism has been levelled at this study. 83 In particular, the measure of outcome employed was whether or not the woman subsequently developed diabetes, whereas it might reasonably be argued that a more important measure would be the success or otherwise of the pregnancy, i.e. the maternal-fetal risk. This aspect was given some attention in a later study by the same group.v' A screening test comprising a single blood glucose measurement 1 h after 50 g of glucose was given to prenatal registrants over a period of about 8 years, and those with values greater than 7· 2 mmol/L were subjected to a 100 g OGTT. Half the 370 or so patients with positive OGTTs were then treated with insulin and half not treated. Perinatal mortality rates were compared and a significantly different risk of 1'5% in treated compared with 6'4% in untreated patients was found in women of 25 years and over, but not in younger patients. The difference was also most noticeable in those who were overweight.
These studies of O'Sullivan and colleagues formed the basis of the criteria for diagnosis of gestational diabetes recommended by the NDDG3 and endorsed by the Second International Workshop-Conference on Gestational Diabetes Mellitus (Table 4 ). 85 Naylor,83 in his extensive and critical review of this subject, expressed his opinion that more attention should have been paid to the degree of glucose intolerance within the category of gestational diabetes. He also felt that the NDDG criteria might be misdirecting current thinking about gestational diabetes.
The WHO adopted a different approach to the diagnosis of gestational diabetes by using its general OGTT protocol and criteria. 56 This meant that a standard 75 g OGTT could be used and the normal interpretative criteria applied with the proviso that the management of a pregnant patient with IGT should be the same as for one with diabetes, i.e, control of blood glucose with either diet or insulin.
In an evaluation of the WHO method in 347 pregnant women diagnosed as gestational diabetic by the NDDG procedure, Li et 01. 86 found that 45% had normal glucose tolerance according to WHO criteria, while 51% showed IGT and 3% had gestational diabetes. This meant that only 54% would have been subjected to diabetic control during their pregnancies if the WHO protocol had been used. These workers also found a significant decrease in the area under the glucose response curve when a 75 g load was used instead of 100 g.
In one of the few recent investigations addressing perinatal outcome, the same authors studied 158 women positive by NDDG criteria but normal or with IGT by WHO criteria." They randomly assigned the patients either to a group treated by diet with glucose monitoring, or to an untreated group. Outcome was satisfactory with no significant differences between the groups, except that those treated for IGT delivered slightly smaller babies (mean 3110 g) one week earlier than the untreated group (mean 3407 g). It was, therefore, concluded that it was safe to replace the NDDG test with the WHO procedure, which would lead to halving the numbers of patients receiving treatment. Similarly, the Diabetic Pregnancy Study Group of the European Association for the Study of Diabetes found no adverse perinatal risk in pregnant women with IGT.88 Nevertheless, some workers claim that there is an increased risk and prefer to err on the side of safety and treat even minor degrees of glucose intolerance." Tallarigo et 01. 90 observed that high blood glucose values in apparently normal pregnant women 2 h after 100 g of glucose were associated with increased incidence of fetal macrosomia, congenital abnormalities, toxaemia and caesarian section. They concluded that even limited degrees of maternal hyperglycaemia could affect the outcome of pregnancy. Others feel zhat a rather more liberal attitude is indicated by the available evidence. 91.92 Even the association between maternal glucose intolerance and fetal macrosomia seems almost to disappear in some studies when maternal age and obesity and other factors are taken into account. 93,94 Furthermore, although excess morbidity is associated with birthweights of 4· 5 kg and over, gestational glucose intolerance in one study was implicated in only 5% of these." It seems therefore that, while gestational glucose intolerance carries an increased risk for the woman of developing diabetes, the risks to the fetus of the milder degrees of intolerance are still not clear, but may be less than generally supposed.
It is likely that the WHO protocol will gain increasing acceptance for the investigation of gestational glucose intolerance as experience accumulates but, at the present time, it is not possible to make a firmer recommendation than this.
Screening for gestational diabetes The perceived need for early detection and careful control of glucose intolerance in pregnancy has led to the introduction of screening programmes in some centres. The Second International Workshop-Conference on Gestational Diabetes Mellitus recommended screening of all pregnant women between the 24th and 28th weeks by means of a 50 g oral glucose load without regard to the time of the last meal or the time of day. 85 If venous plasma glucose at I h after the glucose was 7· 8 mmol/L or more, the report recommended that a full 100 g OGTT should be performed with interpretation according to the criteria in Table 4 , based on the original work of O'Sullivan and Mahan." In contrast, Hong et al. 96 favoured screening on the occasion. of the first prenatal visit to permit early treatment.
Pather'" used a 75 g glucose monohydrate load without fasting the patient and a threshold venous plasma glucose concentration of 8· 4 mmol/L at 1 h. 500 patients were studied in this way and also using a full WHO OGTT protocol. Fifty-five were positive on the screening test; of these two were diabetic and eight had IGT on assessment by the WHO procedure. In two patients with negative screening tests, a full OGTT indicated IGT. Hence, although the sensitivity and specificity of the screening test were high, the predictive value of a positive test was low (22070). Coustan et al. 98 used a 600 Kcal breakfast instead of a glucose load, on the grounds of greater palatability for the patient.
Sutherland et al. 99 developed a mixed-formula 453 Kcal meal containing protein, fat and fibre, as well as carbohydrate, that could be consumed over 10 min. They found this to be more acceptable to patients than a glucose load and it had the advantage of giving a more reproducible glucose response. However, there is currently little sign of agreement amongst experts as to the value of screening for gestational diabetes. They tend to be fairly equally divided depending on whether or not they think the milder degrees of glucose intolerance are likely to have a deleterious effect on the fetus. 89 -92 Most of these screening tests would label more pregnant women as gestational diabetics than would the WHO criteria.
Timing of diagnostic tests for gestational diabetes
Kiihpoo observed an increased insulin response to glucose in normal women at all stages of gestation and a gradually increasing fasting serum insulin during pregnancy. This was not accompanied by any change in fasting serum glucose and no changes in the mean glucose concentration curve occurred until the second half of pregnancy. This finding was interpreted as indicative of diminished peripheral sensitivity to endogenous insulin in pregnancy. Forest et al. l o l derived reference ranges for the 100 g OGTT at different stages of pregnancy and found that both serum glucose and insulin responses to a glucose load increased as pregnancy progressed. Significant differences in serum glucose were observed between each trimester for measurements taken 60 min and 120 min after the load. Hatem et al.,102 using a 75 g OGTT, found an upper limit of normal of 7· 5 mmol/L for the 2-h venous plasma glucose during the second trimester, but this rose to 9· 6 mmol/L during the third trimester. These observations, therefore, suggest that some diminution of glucose tolerance occurs even in normal pregnancy and that different diagnostic criteria may need to be applied at different stages of gestation to take account of this.
The commonly employed time of 24 to 28 weeks gestation for screening for gestational diabetes is something of a compromise between maximum yield of positive results and making a diagnosis sufficiently early to start effective therapy. However, a third of the gestational diabetic patients in the study of Hong et al. 96 had positive screening tests before 24 weeks, which gave rise to their recommendation to screen at the first prenatal visit.
CONCLUSION
The OGTT is still the mainstay for diagnosing diabetes mellitus despite its many disadvantages, which include its intra-individual variability and the difficulty in establishing meaningful criteria for interpretation. Although newer tests such as glycated haemoglobin and fructosamine have been suggested as alternatives, their lack of sensitivity renders them unsuitable for differentiation of borderline cases, and overt cases can usually be diagnosed by means of random or fasting plasma glucose concentrations. Furthermore, calibration problems and method differences make comparison between different centres difficult.
Modern criteria for interpreting OGTTs are set so as to diagnose fewer cases of diabetes than the older criteria, acknowledging that mild degrees of glucose intolerance can occur without conferring significant risk on an individual. However, the category of IGT is still a controversial one, with some authors regarding it as unstable and unhelpful. Nevertheless, there is now reasonable international agreement with respect to methods for diagnosing diabetes in nonpregnant subjects. There is far less agreement where gestational diabetes is concerned, with many workers relying on criteria that arguably were established with the wrong end-point in mind. However, there does not yet seem to be enough evidence on perinatal outcome to resolve the matter entirely in favour of the newer diagnostic criteria that would label fewer women as gestational diabetics and a multi-centre trial is really needed to accumulate enough information for meaningful statistical analysis. Current opinion favours fetal hyperinsulinaemia as the cause of perinatal morbidity in diabetic pregnancy, rather than maternal hyperglycaemia per se, although the two are usually related.'?' The risk to the fetus also appears to increase with increasing carbohydrate intolerance, so that mild degrees of glucose intolerance, such as occur in many cases of IGT, may pose less of a risk than treatment with insulin.
Much of the currently available data has been acquired using outdated techniques and interpreted according to criteria of doubtful validity. A firmer database is therefore required before a recommendation can be given about the benefits, or otherwise, of generalized screening for gestational diabetes.
In the future, immunological, cytogenetic and molecular genetic techniques and measurements of parameters such as insulin and insulin precursor concentrations may be helpful diagnostically and would provide information about the type of diabetes (e.g. type I or type II) as well as the basic diagnosis. There is also the possibility that the introduction of a standardized meal, rather than a glucose load, might reduce the within-individual variation that is a major disadvantage of the OGTT at present. However, this still needs to be assessed and validated.
APPENDIX

Instructions for performing tbe oral glucose tolerance test
The OGTI should be performed in cases where random or fasting plasma glucose measurements are unable to categorize an individual. The test should be administered in the morning after an overnight fast of between 10 h and 16 h, during which only water may be drunk. For at least 3 days prior to the test, the patient should have had a normal unrestricted diet containing at least 150 g of carbohydrate and should have been normally physically active. Any recent infections or current medication should be noted. Ideally, any medication known to influence blood glucose should be discontinued, if possible for a period equivalent to five times the effective half-life of the drug. Smoking should be discouraged at all stages, but should be prohibited on the morning of the test.
During the test, the patient should be encouraged to sit quietly. A fasting blood specimen should be collected and an adult patient given a solution of 75 g of glucose to drink in a volume of approximately 300 mL over 5 min. Current WHO opinion is that this should be 75 g of anhydrous glucose or 82' 5 g of monohydrate. The test load for a child should be I' 75 g per kg up to a maximum total of 75 g of glucose. Equivalent solutions of partial hydrolysates of starch in similar volumes are also considered acceptable (see text).
Further blood samples are usually collected at halfhour intervals for up to 2 h after administration of the load, but a fasting and a 2-h sample are adequate for assessment. Blood samples must be preserved appropriately for the method of analysis. Sodium fluoride is the most commonly employed preservative, but it is not completely effective in preventing glycolysis. ' M , IOI Cooling the samples with ice slows down the disappearance of glucose but specimens should be assayed as soon as possible by a laboratory method specific for glucose. Strip testing methods must not be used for diagnostic glucose measurements. Assay results should be interpreted by comparison with the appropriate WHO criteria, according to the type of blood specimen collected and whether whole blood or plasma has been assayed."
